Expression of CYP2S1 in human hepatic stellate cells

FEBS Letters

Volumn 581, Issue 4, 2007, Pages 781-786

  Marek, Carylyn J ^a   Tucker, Steven J ^a   Koruth, Matthew ^a   Wallace, Karen ^a,b   Wright, Matthew C ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b School of Clinical   (United Kingdom)

Author keywords

CYP1B1; CYP4F3; Cytochrome P450; Fibrosis; Liver; retinoids

Indexed keywords

CYTOCHROME P450 11B1; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 20A1; CYTOCHROME P450 27B1; CYTOCHROME P450 2C9; CYTOCHROME P450 2E1; CYTOCHROME P450 2S1; CYTOCHROME P450 4F11; CYTOCHROME P450 4F3; CYTOCHROME P450 51A1; CYTOCHROME P450 7B1; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER FIBROSIS; LIVER INJURY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; STELLATE CELL; TESTOSTERONE METABOLISM;

CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER;

EID: 33846794564     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.01.056     Document Type: Article

References (22)

1. Paine A.J. The cytochrome P450 gene superfamily. Int. J. Exp. Pathol. 72 (1991) 349-363
2. Friedman S.L., and Bansal M.B. Reversal of hepatic fibrosis - fact or fantasy?. Hepatology 43 Suppl. 1 (2006) S82-S88
3. Papatheodoridis G.V., and Cholongitas E. Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options. J. Viral Hepatol. 11 (2004) 287-296
4. Patterson L.H., McKeown S.R., Robson T., Gallagher R., Raleigh S.M., and Orr S. Antitumour prodrug development using cytochrome P450 (CYP) mediated activation. Anticancer Drug Des. 14 (1999) 473-486
5. Patterson L.H., and Murray G.I. Tumour cytochrome P450 and drug activation. Curr. Pharm. Des. 8 (2002) 1335-1347
6. Haughton E.L., Tucker S.J., Marek C.J., Durward E., Leel V., Bascal Z., Monaghan T., Koruth M., Collie-Duguid E., Mann D.A., Trim J.E., and Wright M.C. Pregnane X receptor activators inhibit human hepatic stellate cell trans-differentiation in vitro. Gastroenterology 131 (2006) 194-209
7. Elrick L.J., Leel V., Blaylock M.G., Duncan L., Drever M.R., Strachan G., Charlton K.A., Koruth M., Porter A.J., and Wright M.C. Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells - a potential mechanism for targeting liver anti-fibrotic therapeutics. J. Hepatol. 42 (2005) 888-896
8. Marek C.J., Tucker S.J., Konstantinou D.K., Elrick L.J., Haefner D., Sigalas C., Murray G.I., Goodwin B., and Wright M.C. Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms. Biochem. J. 387 (2005) 601-608
9. Guengerich F.P., Dannan G.A., Wright S.T., Martin M.V., and Kaminsky L.S. Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphthoflavone. Biochemistry 21 (1982) 6019-6030
10. Waxman D.J. P450-catalyzed steroid hydroxylation: assay and product identification by thin-layer chromatography. Methods Enzymol. 206 (1991) 462-476
11. Piscaglia F., Knittel T., Kobold D., Barnikol-Watanabe S., Di Rocco P., and Ramadori G. Cellular localization of hepatic cytochrome 1B1 expression and its regulation by aromatic hydrocarbons and inflammatory cytokines. Biochem. Pharmacol. 58 (1999) 157-165
12. Parola M., Robino G., Bordone R., Leonarduzzi G., Casini A., Pinzani M., Neve E., Bellomo G., Dianzani M.U., Ingelman-Sundberg M., and Albano E. Detection of cytochrome P4503A (CYP3A) in human hepatic stellate cells. Biochem. Biophys. Res. Commun. 238 (1997) 420-424
13. Lehmann J.M., McKee D.D., Watson M.A., Willson T.M., Moore J.T., and Kliewer S.A. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102 (1998) 1016-1023
14. Murray G.I., Melvin W.T., Greenlee W.F., and Burke M.D. Regulation, function and tissue-specific expression of cytochrome P450 CYP1B1. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 297-316
15. Harvey J.L., Paine A.J., and Wright M.C. Disruption of endogenous regulator homeostasis underlies the mechanism of rat CYP1A1 mRNA induction by metyrapone. Biochem. J. 331 (1998) 273-281
16. Rannug A., and Fritsche E. The aryl hydrocarbon receptor and light. Biol. Chem. 387 (2006) 1149-1157
17. Oberg M., Bergander L., Hakansson H., Rannug U., and Rannug A. Identification of the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity. Toxicol. Sci. 85 (2005) 935-943
18. Gonzalez F.J. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat. Res. 569 (2005) 101-110
19. Nieto N., Friedman S.L., and Cederbaum A.I. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology 35 (2002) 62-73
20. Smith G., Wolf C.R., Deeni Y.Y., Dawe R.S., Evans A.T., Comrie M.M., Ferguson J., and Ibbotson S.H. Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 361 (2003) 1336-1343
21. Saarikoski S.T., Wikman H.A., Smith G., Wolff C.H., and Husgafvel-Pursiainen K. Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridization and immunohistochemistry. J. Histochem. Cytochem. 53 (2005) 549-556
22. Le Quere V., Plee-Gautier E., Potin P., Madec S., and Salaun J.P. Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. J. Lipid Res. 45 (2004) 1446-1458